Surgery Partners (NASDAQ:SGRY) Posts Earnings Results, Misses Expectations By $0.04 EPS

Surgery Partners (NASDAQ:SGRY - Get Free Report) announced its quarterly earnings results on Monday. The company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04), Briefing.com reports. The company had revenue of $776.00 million for the quarter, compared to analyst estimates of $777.77 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm's revenue for the quarter was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.10 earnings per share. Surgery Partners updated its FY 2025 guidance to EPS.

Surgery Partners Stock Performance

Shares of NASDAQ SGRY opened at $23.26 on Tuesday. The stock has a fifty day moving average price of $22.60 and a two-hundred day moving average price of $23.32. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The firm has a market cap of $2.98 billion, a P/E ratio of -48.46, a PEG ratio of 19.21 and a beta of 1.96. Surgery Partners has a 1 year low of $19.50 and a 1 year high of $33.97.

Insider Buying and Selling at Surgery Partners

In other news, insider Marissa Brittenham sold 3,156 shares of the firm's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.09, for a total transaction of $76,028.04. Following the completion of the sale, the insider now directly owns 63,408 shares of the company's stock, valued at $1,527,498.72. This trade represents a 4.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO David T. Doherty sold 6,733 shares of the firm's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now directly owns 150,868 shares of the company's stock, valued at approximately $3,623,849.36. This represents a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently commented on SGRY shares. Royal Bank of Canada restated an "outperform" rating and issued a $35.00 target price on shares of Surgery Partners in a research report on Tuesday, March 25th. Benchmark restated a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a research report on Monday, April 21st. Finally, Macquarie lowered their target price on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, Surgery Partners currently has an average rating of "Moderate Buy" and a consensus target price of $34.75.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.